Dizon, Glenda D.

HRN: 10-65-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/23/2026
07/30/2026
IVTT
900mg
Q8H
INFECTED DM FOOT
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: